New stent shows promise for faster artery healing in heart patients
NCT ID NCT06214819
First seen Jan 11, 2026 · Last updated May 17, 2026 · Updated 20 times
Summary
This study tests a new drug-coated heart stent (VIVO ISAR) against a standard one (XIENCE Skypoint) in 40 people with coronary artery disease. Each patient receives both stents in different blocked arteries, and a special camera checks healing after one month. The goal is to see which stent allows faster artery lining growth, which may reduce future heart risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic Barcelona
Barcelona, 08036, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, 08035, Spain
-
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, 08907, Spain
-
Hospital Universitario de Gerona Doctor Josep Trueta
Girona, 17007, Spain
Conditions
Explore the condition pages connected to this study.